It has been shown that the most effective means of preventing Glaucoma damage is to reduce IOP. By this, blood flow to the nerve tissue is improved and nerve damage progression is slowed down or stopped. Therefore, the primary goal of the treatment is to reduce the elevated intraocular pressure.
Current treatments for Open Angle Glaucoma (OAG) include medications, Laser Trabeculoplasty, and a variety of surgical solutions. Treatment will depend on the progression of the disease, as well as both the patient’s tolerance to the course of therapy and its efficacy in reducing IOP.
Medicinal treatment is often considered the first line of defense. Given the complexity of regimens, the chronic use of multiple medications, the need for daily administration, the absence of a beneficial effect that can be observed by the patient and the side effects, patients often do not take their medication consistently, raising a significant problem of non-compliance. When medicine is no longer effective, many physicians will incorporate Laser Trabeculoplasty however it also has not be able to prove a long-term reduction of IOP. Once that fails, the standard of care of treatment is by a surgical procedure to increase the drainage.
CLASS procedure is just one of the surgical alternatives for the treatment of glaucoma and with its proven efficacy and elevated safety profile, is becoming a popular choice for surgeons and patients alike.
Your physician will plan the best treatment regimen suitable for your condition based on efficacy, safety and tolerability.
Surgical Procedures for Reduction of IOP
All glaucoma surgical procedures are based on the creation of an alternative drainage pathway in the eye. Instead of draining into the normal drainage site of the eye (trabecular meshwork) which is blocked, the fluid is drained into a new space “the bleb” that is completely covered by the white outer covering (conjunctiva) of the eye.
The purpose of this alternative drainage is to achieve a significant IOP reduction that will reduce or halt the disease progression.